Pleiotrophin Interaction with Synthetic Glycosaminoglycan Mimetics

Area of Science:

• Biochemistry
• Neuroscience
• Structural Biology

Background:

• Chondroitin sulfate (CS) E is the natural ligand for pleiotrophin (PTN) in the embryonic central nervous system (CNS).
• While PTN structures exist, its precise binding site for CS-E remains uncharacterized.
• Understanding this interaction is crucial for CNS development research.

Purpose of the Study:

• To identify the precise binding site and mode of interaction between PTN and CS-E.
• To investigate if a minimal CS-E sequence (tetrasaccharide) is sufficient for full PTN interaction.
• To explore the role of PTN's intrinsically disordered region (IDR) in binding.

Main Methods:

• Utilized ¹⁵N-labeled PTN and Heteronuclear Single Quantum Coherence (HSQC) Nuclear Magnetic Resonance (NMR) spectroscopy.
• Studied interactions with synthetic CS-E tetrasaccharides, including modified versions.
• Analyzed NMR data to determine binding site characteristics and dynamics.

Main Results:

• Confirmed that a synthetic CS-E tetrasaccharide is sufficient to fully interact with PTN, consistent with larger glycosaminoglycan (GAG) sequences.
• Identified a conserved binding site and mode for both unmodified and benzylated CS-E tetrasaccharides.
• Observed evidence suggesting PTN's central region is an intrinsically disordered region (IDR) that may change upon binding.

Conclusions:

• A synthetic CS-E tetrasaccharide effectively binds to PTN, revealing the minimum required sequence for interaction.
• The binding site and mode are conserved across different CS-E structures, including those with benzyl modifications.
• PTN's potential IDR modulation upon binding warrants further investigation in CNS development contexts.